These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12860175)

  • 1. Old and new vaccine approaches.
    Arnon R; Ben-Yedidia T
    Int Immunopharmacol; 2003 Aug; 3(8):1195-204. PubMed ID: 12860175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically engineered vaccines: an overview.
    Dertzbaugh MT
    Plasmid; 1998; 39(2):100-13. PubMed ID: 9514708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of vaccine research and development: the human immunodeficiency virus (HIV).
    Girard MP; Osmanov SK; Kieny MP
    Vaccine; 2006 May; 24(19):4062-81. PubMed ID: 16530298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-viral vector as vaccine carrier.
    Chen WC; Huang L
    Adv Genet; 2005; 54():315-37. PubMed ID: 16096017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.
    Woo WP; Doan T; Herd KA; Netter HJ; Tindle RW
    J Virol; 2006 Apr; 80(8):3975-84. PubMed ID: 16571814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors.
    Walcher P; Mayr UB; Azimpour-Tabrizi C; Eko FO; Jechlinger W; Mayrhofer P; Alefantis T; Mujer CV; DelVecchio VG; Lubitz W
    Expert Rev Vaccines; 2004 Dec; 3(6):681-91. PubMed ID: 15606353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New technologies for vaccine development].
    Leclerc C
    Med Sci (Paris); 2007 Apr; 23(4):386-90. PubMed ID: 17433228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of immunomodulating molecules by recombinant viruses: can the immunogenicity of live virus vaccines be improved?
    Bukreyev A; Belyakov IM
    Expert Rev Vaccines; 2002 Aug; 1(2):233-45. PubMed ID: 12901562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translational research on vaccines: influenza as an example.
    Belshe RB
    Clin Pharmacol Ther; 2007 Dec; 82(6):745-9. PubMed ID: 17971813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Listeria monocytogenes as novel carrier system for the development of live vaccines.
    Schoen C; Loeffler DI; Frentzen A; Pilgrim S; Goebel W; Stritzker J
    Int J Med Microbiol; 2008 Jan; 298(1-2):45-58. PubMed ID: 17936682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel peptide-based vaccines efficiently prime murine "help"-independent CD8+ T cell responses in the liver.
    Dikopoulos N; Riedl P; Schirmbeck R; Reimann J
    Hepatology; 2004 Aug; 40(2):300-9. PubMed ID: 15368434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope.
    Lu Y; Ouyang K; Fang J; Zhang H; Wu G; Ma Y; Zhang Y; Hu X; Jin L; Cao R; Fan H; Li T; Liu J
    Vaccine; 2009 Aug; 27(39):5411-8. PubMed ID: 19616501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination against equine influenza: quid novi?
    Paillot R; Hannant D; Kydd JH; Daly JM
    Vaccine; 2006 May; 24(19):4047-61. PubMed ID: 16545507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for the development of safe and effective DNA vaccines for allergy treatment.
    Hartl A; Weiss R; Hochreiter R; Scheiblhofer S; Bauer R; Valenta R; Ferreira F; Leitner W; Thalhamer J
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003; (94):279-98; discussion 299. PubMed ID: 15119049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple copies of a tumor epitope in a recombinant hepatitis B surface antigen (HBsAg) vaccine enhance CTL responses, but not tumor protection.
    Haigh O; Guo H; Edgtton K; Mather M; Herd KA; Tindle RW
    Virology; 2007 Nov; 368(2):363-75. PubMed ID: 17689584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal immunization using recombinant plant-based oral vaccines.
    Streatfield SJ
    Methods; 2006 Feb; 38(2):150-7. PubMed ID: 16431131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of marker vaccine and differential diagnostic test technology.
    Henderson LM
    Biologicals; 2005 Dec; 33(4):203-9. PubMed ID: 16257545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potency assays for therapeutic live whole cell cancer vaccines.
    Petricciani J; Egan W; Vicari G; Furesz J; Schild G
    Biologicals; 2007 Apr; 35(2):107-13. PubMed ID: 16882459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Herpes simplex virus vaccine studies: from past to present].
    Us D
    Mikrobiyol Bul; 2006 Oct; 40(4):413-33. PubMed ID: 17205702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.